Biotechnology News MICARDIS Search

| Biotechnology feed | All feeds

BioNews
Biotechnology, Pharmaceutical and Life Science News

Search Results

Documents 1-6 out of 6 found

Current Search: micardis: 6

Micardis approved to reduce cardiovascular risk
ngelheim wish to announce that the European Commission has approved Micardis (telmisartan) for the reduction of cardiovascular morbidity in patients with: I.

manifest atherothrombotic cardiovascular disease (history of coronary heart disease, stroke, or...

Irish Medical Times: Feb 3 2010 7:52PM
Matching: micardis

Find similar documents

Micardis Now Indicated for Cardiovascular Prevention in High Risk Patients
ACE inhibitor, acetylcholinesterase inhibitor, aciclovir, acne, acute coronary syndrome, acute lymphoblastic leukaemia, ADHD, advanced prostate cancer, advanced renal cell carcinoma, advanced soft tissue sarcoma, adverse reaction, agomelatine, agoraphobia,...

Irish Medical Times: Feb 1 2010 7:59PM
Matching: micardis

Find similar documents

New Research Report: Malaysia Pharmaceuticals & Healthcare Report Q1 2010
In BMI's Business Environment Rating (BER) matrix for Q409, Malaysia considerably improved its position in the Asia Pacific matrix, and is now ranked fifth out of the 15 key regional markets.

Key attractions of the Malaysian pharmaceutical market are the...

PR inside: Jan 31 2010 6:51PM
Matching: micardis

Find similar documents

Report: Combo hypertension drugs could provide lower doses, be safer
FURTHER READING Company Decision Resources Novartis Person Nikhil Mehta Product amlodipine Diovan Micardis Norvasc Tareg telmisartan Topic angiotensin II receptor antagonist calcium channel blocker hypertension Pharmaceutical telmisartan Portals...

Cardiovascular Business: Jan 15 2010 7:45AM
Matching: micardis

Find similar documents

ARBs like Diovan may prevent, treat Alzheimer's
Here's a new indication lots of drugmakers would like: Researchers have found that blood pressure meds sold by AstraZeneca, Sanofi-Aventis, Merck and others might also cut the risk of developing Alzheimer's disease.

Published in the British Medical Journal ,...

FiercePharma: Jan 13 2010 4:52PM
Matching: micardis

Find similar documents

Committee For Medicinal Products For Human Use Summary Of Positive Opinion For Telmisartan Teva
International Nonproprietary Name (INN): telmisartan LONDON, Nov.

19, 2009-On 19 November 2009 the Committee for Medicinal Products for Human Use (CHMP), having considered new information, adopted a positive opinion, recommending to grant a marketing...

Pharma Live: Nov 20 2009 5:11PM
Matching: micardis

Find similar documents

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.